These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1326902)

  • 21. Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.
    Caputo F; Vignoli T; Maremmani I; Bernardi M; Zoli G
    Int J Environ Res Public Health; 2009 Jun; 6(6):1917-29. PubMed ID: 19578468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintaining abstinence from alcohol with gamma-hydroxybutyric acid.
    Addolorato G; Cibin M; Capristo E; Beghe F; Gessa G; Stefanini GF; Gasbarrini G
    Lancet; 1998 Jan; 351(9095):38. PubMed ID: 9433435
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal.
    Gallimberti L; Schifano F; Forza G; Miconi L; Ferrara SD
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(3):113-4. PubMed ID: 7803523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial.
    Guiraud J; Addolorato G; Antonelli M; Aubin HJ; de Bejczy A; Benyamina A; Cacciaglia R; Caputo F; Dematteis M; Ferrulli A; Goudriaan AE; Gual A; Lesch OM; Maremmani I; Mirijello A; Nutt DJ; Paille F; Perney P; Poulnais R; Raffaillac Q; Rehm J; Rolland B; Rotondo C; Scherrer B; Simon N; Skala K; Söderpalm B; Somaini L; Sommer WH; Spanagel R; Vassallo GA; Walter H; van den Brink W
    J Psychopharmacol; 2022 Oct; 36(10):1136-1145. PubMed ID: 35796481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
    Huang MC; Chen CH; Pan CH; Lin SK
    J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
    Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
    Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
    Johnson BA; Ait-Daoud N; Bowden CL; DiClemente CC; Roache JD; Lawson K; Javors MA; Ma JZ
    Lancet; 2003 May; 361(9370):1677-85. PubMed ID: 12767733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
    Gann H; Feige B; Cloot O; Van Wasen H; Zinzgraf D; Hohagen F; Riemann D
    Pharmacopsychiatry; 2004 Sep; 37(5):228-35. PubMed ID: 15359376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity.
    Caputo F; Francini S; Brambilla R; Vigna-Taglianti F; Stoppo M; Del Re A; Leggio L; Addolorato G; Zoli G; Bernardi M
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):450-6. PubMed ID: 21276717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial in alcohol relapse prevention: role of atenolol, alcohol craving, and treatment adherence.
    Gottlieb LD; Horwitz RI; Kraus ML; Segal SR; Viscoli CM
    J Subst Abuse Treat; 1994; 11(3):253-8. PubMed ID: 8072054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.
    Caputo F; Vignoli T; Tarli C; Domenicali M; Zoli G; Bernardi M; Addolorato G
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26959045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of alcohol during the treatment of alcohol dependence with gamma-hydroxybutyric acid: risk of severe events are avoided by the dose fractioning of the drug.
    Caputo F; Stoppo M; Vignoli T; Francini S; Lorenzini F; Bernardi M
    J Clin Psychopharmacol; 2007 Aug; 27(4):418. PubMed ID: 17632241
    [No Abstract]   [Full Text] [Related]  

  • 33. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
    Dahl H; Hammarberg A; Franck J; Helander A
    Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Severe delirium in withdrawal from chronic gamma-hydroxybutyric acid consumption].
    Proest G; Zschernack T; Stelzig M; Steinacher B
    Nervenarzt; 2009 May; 80(5):607-8. PubMed ID: 19252889
    [No Abstract]   [Full Text] [Related]  

  • 36. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.
    Chick J; Anton R; Checinski K; Croop R; Drummond DC; Farmer R; Labriola D; Marshall J; Moncrieff J; Morgan MY; Peters T; Ritson B
    Alcohol Alcohol; 2000; 35(6):587-93. PubMed ID: 11093966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal.
    Nimmerrichter AA; Walter H; Gutierrez-Lobos KE; Lesch OM
    Alcohol Alcohol; 2002; 37(1):67-73. PubMed ID: 11825860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.